KALA BIO (KALA) News Today $1.66 +0.02 (+0.91%) As of 10:31 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KALA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period KALA BIO (NASDAQ:KALA) Major Shareholder Bros. Advisors Lp Baker Sells 216,801 SharesOctober 3, 2025 | insidertrades.comKALA BIO (NASDAQ:KALA) Stock Rating Lowered by MizuhoOctober 2, 2025 | americanbankingnews.comHC Wainwright Reiterates Neutral Rating for KALA BIO (NASDAQ:KALA)October 1, 2025 | americanbankingnews.comKALA BIO (NASDAQ:KALA) Lowered to "Hold" Rating by Lifesci CapitalOctober 1, 2025 | americanbankingnews.comKALA BIO (NASDAQ:KALA) Downgraded to Hold Rating by Lifesci CapitalSeptember 30, 2025 | marketbeat.comKALA BIO (NASDAQ:KALA) Cut to Neutral at LADENBURG THALM/SH SHSeptember 30, 2025 | americanbankingnews.comKala Bio plunges after scrapping development of lead drugSeptember 29, 2025 | reuters.comThese Penny Stocks are Dropping Today: IOBT, KALA, BYNDSeptember 29, 2025 | 247wallst.comKala Bio stock plunges after failed Phase 2b trial for eye treatmentSeptember 29, 2025 | za.investing.comKala Bio Shares Plummet After Eye Defect Treatment Misses EndpointsSeptember 29, 2025 | marketwatch.comKala Bio scraps development of eye disease drug after trial failureSeptember 29, 2025 | msn.comBiotech company to lay off half its workforce after eye drug fails trialSeptember 29, 2025 | bizjournals.comKala Bio Stock Just Plunged 92% Today – Here’s What HappenedSeptember 29, 2025 | msn.comKala Bio to Stop Eye Defect Treatment Development After Study Misses Primary EndpointSeptember 29, 2025 | marketwatch.comKALA BIO Announces Topline Results from CHASE Phase 2b Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) Did Not Meet Primary ...September 29, 2025 | finance.yahoo.comKala Pharmaceuticals Halts KPI-012 Development After Trial FailureSeptember 29, 2025 | tipranks.comFY2025 EPS Estimates for KALA BIO Raised by HC WainwrightSeptember 20, 2025 | marketbeat.comHC Wainwright Forecasts Strong Price Appreciation for KALA BIO (NASDAQ:KALA) StockSeptember 18, 2025 | marketbeat.comHere's Why Point72's Steve Cohen's Bought Millions Worth of Biotech Stocks Last WeekSeptember 17, 2025 | msn.comKALA BIO (NASDAQ:KALA) Stock Price Expected to Rise, Oppenheimer Analyst SaysSeptember 13, 2025 | marketbeat.comKALA BIO (NASDAQ:KALA) Now Covered by MizuhoSeptember 10, 2025 | marketbeat.comKALA BIO, Inc. (NASDAQ:KALA) Given Consensus Recommendation of "Buy" by AnalystsSeptember 10, 2025 | marketbeat.comMizuho Initiates Coverage of KALA BIO (KALA) with Outperform RecommendationSeptember 9, 2025 | msn.comQ3 Earnings Forecast for KALA BIO Issued By Lifesci CapitalSeptember 7, 2025 | marketbeat.comKALA BIO, Inc.'s (NASDAQ:KALA) market cap surged US$28m last week, retail investors who have a lot riding on the company were rewardedSeptember 6, 2025 | finance.yahoo.comKALA BIO (NASDAQ:KALA) Upgraded by Lifesci Capital to Strong-Buy RatingSeptember 6, 2025 | marketbeat.comADAR1 Capital Management LLC Buys 78,582 Shares of KALA BIO, Inc. $KALASeptember 4, 2025 | marketbeat.comKALA BIO (NASDAQ:KALA) Trading Up 5.9% - Time to Buy?September 3, 2025 | marketbeat.comKALA BIO to Present at H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 3, 2025 | finance.yahoo.comHC Wainwright Has Positive Estimate for KALA BIO Q3 EarningsAugust 17, 2025 | marketbeat.comKALA BIO, Inc.: KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 8, 2025 | finanznachrichten.deKALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 8, 2025 | globenewswire.comKALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual ConferenceAugust 6, 2025 | globenewswire.comKALA BIO (KALA) to Release Earnings on TuesdayJuly 30, 2025 | marketbeat.comKALA BIO (NASDAQ:KALA) Upgraded by Wall Street Zen to Hold RatingJuly 28, 2025 | marketbeat.comKALA BIO Announces Completion of Enrollment in CHASE Clinical Trial ...July 11, 2025 | morningstar.comMKALA BIO Completes Patient Enrollment in CHASE Phase 2b Trial ... - NasdaqJuly 11, 2025 | nasdaq.comKALA BIO Inc. (KALA) Stock Price Today - WSJ - The Wall Street JournalJuly 10, 2025 | wsj.comKALA BIO, Inc.: KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)July 9, 2025 | finanznachrichten.deKala Pharmaceuticals Completes Enrollment for Phase 2b TrialJuly 9, 2025 | tipranks.comKALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)July 9, 2025 | globenewswire.comKala Bio Inc Valuation - MorningstarJuly 8, 2025 | morningstar.comMKALA BIO, Inc. (KALA) - Yahoo FinanceJuly 1, 2025 | finance.yahoo.comKALA BIO, Inc. (NASDAQ:KALA) CFO Sells $14,560.31 in StockJune 27, 2025 | insidertrades.comMary Reumuth Sells 2,850 Shares of KALA BIO, Inc. (NASDAQ:KALA) StockJune 5, 2025 | insidertrades.comKALA BIO to Present at Jefferies Global Healthcare ConferenceMay 29, 2025 | globenewswire.comKALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 14, 2025 | finance.yahoo.comKALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateMarch 31, 2025 | markets.businessinsider.comKALA BIO to Present at TD Cowen 45th Annual Health Care ConferenceFebruary 26, 2025 | finance.yahoo.comKALA BIO's (KALA) "Buy" Rating Reiterated at HC WainwrightFebruary 13, 2025 | marketbeat.com Get KALA BIO News Delivered to You Automatically Sign up to receive the latest news and ratings for KALA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KALA Media Mentions By Week KALA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KALA News Sentiment▼-0.270.55▲Average Medical News Sentiment KALA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KALA Articles This Week▼42▲KALA Articles Average Week Get the Latest News and Ratings for KALA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for KALA BIO and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BioAtla News Today Jasper Therapeutics News Today Elutia News Today Senti Biosciences News Today OnKure Therapeutics News Today Rani Therapeutics News Today Mural Oncology News Today Eagle Pharmaceuticals News Today Alterity Therapeutics News Today Tenax Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KALA) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredHow to profit from the AI maniaPorter Stansberry says the AI boom’s next trillion-dollar winners won’t be chatbots or Big Tech — but the over...Porter & Company | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored3 Major A.I. Threats That Could Upend the U.S. EconomyThe media's calling Artificial Intelligence a "revolution," but for many Americans, the real impact might actu...Goldco Precious Metals | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KALA BIO, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KALA BIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
